BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 23 filers reported holding BAXTER INTL INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baron Wealth Management LLC | 28,645 | $1,107,416 | 0.61% |
| TRUST CO OF TOLEDO NA /OH/ | 26,666 | $1,030,908 | 0.18% |
| NEVILLE RODIE & SHAW INC | 25,280 | $977 | 0.08% |
| Anchor Investment Management, LLC | 13,817 | $534,183 | 0.06% |
| ROWLANDMILLER & PARTNERS.ADV | 6,701 | $259,064 | 0.06% |
| Czech National Bank | 88,854 | $3,435,096 | 0.05% |
| M&R CAPITAL MANAGEMENT INC | 4,090 | $158,119 | 0.04% |
| CACTI ASSET MANAGEMENT LLC | 6,500 | $251,290 | 0.02% |
| EXCHANGE TRADED CONCEPTS, LLC | 17,990 | $695,493 | 0.02% |
| DnB Asset Management AS | 83,017 | $3,209,437 | 0.02% |
| Bartlett & Co. LLC | 22,507 | $882 | 0.01% |
| PARK NATIONAL CORP /OH/ | 8,760 | $338,662 | 0.01% |
| Symmetry Partners, LLC | 6,885 | $267 | 0.01% |
| Pure Financial Advisors, LLC | 8,400 | $324,727 | 0.01% |
| FULTON BANK, N.A. | 5,742 | $221,985 | 0.01% |
| Diversified Trust Co | 6,380 | $246,682 | 0.01% |
| OPTIMUM INVESTMENT ADVISORS | 280 | $10,825 | 0.01% |
| TOMPKINS FINANCIAL CORP | 1,000 | $38,660 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 1,797 | $69,472 | 0.00% |
| Pacifica Partners Inc. | 100 | $3,580 | 0.00% |
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists BAXTER INTL INC's shareholders in Q4 2023. To view BAXTER INTL INC's shareholder history, click here.